In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study

In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study

Background: Diffusion tensor imaging (DTI) can identify amyotrophic lateral sclerosis (ALS)-associated patterns of brain alterations at the group level according to a neuropathological staging system. Objective: The study was designed to investigate the in vivo staging in ALS patients with the C9orf...

Full description

Bibliographic Details
Main Authors:	Hans-Peter Müller, Kelly Del Tredici, Dorothée Lulé, Kathrin Müller, Jochen H. Weishaupt, Albert C. Ludolph, Jan Kassubek
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	NeuroImage: Clinical
Subjects:	Diffusion tensor imaging Amyotrophic lateral sclerosis C9orf72 expansion Magnetic resonance imaging Motor neuron diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158220301352

Similar Items

Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype
by: Mary Kay Floeter, et al.
Published: (2016-01-01)

Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
by: Xiaoqiang Tang, et al.
Published: (2020-06-01)

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
by: Hannah Rostalski, et al.
Published: (2019-05-01)

Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients
by: Francesca Trojsi, et al.
Published: (2019-05-01)

RNA Misprocessing in C9orf72-Linked Neurodegeneration
by: Holly V. Barker, et al.
Published: (2017-07-01)

A comparative bioinformatic analysis of C9orf72
by: Shalini Iyer, et al.
Published: (2018-02-01)

Two Families with SOD1 (L144F) and C9orf72 Gene Mutations and an Overview of Amyotrophic Lateral Sclerosis
by: Nazlı Gamze Bülbül, et al.
Published: (2018-06-01)

Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72
by: Carl Laflamme, et al.
Published: (2019-10-01)

C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies
by: Laura de Godoy Rousseff Prado, et al.

G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo
by: Roberto Simone, et al.
Published: (2018-01-01)

Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats
by: Wei Dong, et al.
Published: (2020-09-01)

Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
by: Qihui Zhou, et al.
Published: (2020-02-01)

Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72
by: Mary Kay Floeter, et al.
Published: (2018-12-01)

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
by: Petra Frick, et al.
Published: (2018-08-01)

Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions
by: Rachel Smallwood Shoukry, et al.
Published: (2020-01-01)

The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion
by: Emma M Devenney, et al.
Published: (2017-01-01)

Evaluation of methylation status of the 5’-promoter region of C9orf72 gene in Russian patients with neurodegenerative diseases
by: Yu. A. Shpilyukova, et al.
Published: (2018-07-01)

RNA-mediated toxicity in C9orf72 ALS and FTD
by: Zachary T. McEachin, et al.
Published: (2020-11-01)

The Enigmatic Role of C9ORF72 in Autophagy
by: Melissa Nassif, et al.
Published: (2017-08-01)

Modeling C9ORF72 loss-of-function : a knockdown mouse model
by: Lopez-Herdoiza, Maria Belen
Published: (2016)

BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
by: Hannah Rostalski, et al.
Published: (2020-10-01)

Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
by: Mehdi Ghasemi, et al.
Published: (2021-01-01)

Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
by: Jeannie Chew, et al.
Published: (2019-02-01)

Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ALS/FTD is rescued by SV2 replenishment
by: Brigid K Jensen, et al.
Published: (2020-05-01)

Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation
by: Meena Kumari Kotni, et al.
Published: (2016-11-01)

Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study
by: Sonja Schönecker, et al.
Published: (2018-03-01)

Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease—The Example of C9orf72 ALS
by: Marije F. W. Semmelink, et al.
Published: (2021-08-01)

C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import
by: Lindsey R Hayes, et al.
Published: (2020-03-01)

Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
by: Matthew P. Shaw, et al.
Published: (2018-11-01)

Pesquisa da mutação C9ORF72 e de suas características clínicas nos pacientes portadores de esclerose lateral amiotrófica, demência frontotemporal e parkinsonismo atípico
by: Daniel Sabino de Oliveira
Published: (2016)

Pesquisa da mutação C9ORF72 e de suas características clínicas nos pacientes portadores de esclerose lateral amiotrófica, demência frontotemporal e parkinsonismo atípico
by: Oliveira, Daniel Sabino de
Published: (2016)

UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction
by: Benjamin L. Zaepfel, et al.
Published: (2021-03-01)

Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
by: Dennis W. Dickson, et al.
Published: (2019-10-01)

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
by: Suzee E. Lee, et al.
Published: (2017-01-01)

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
by: Alexander Schmitz, et al.
Published: (2021-02-01)

Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers
by: Jazmyne L. Jackson, et al.
Published: (2020-01-01)

Forward genetic screen in Caenorhabditis elegans suggests F57A10.2 and acp-4 as suppressors of C9ORF72 related phenotypes
by: XIN WANG, et al.
Published: (2016-11-01)

Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels
by: Shangxi Xiao, et al.
Published: (2019-10-01)

Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
by: Ranjan Batra, et al.
Published: (2017-07-01)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
by: Elaine Y. Liu, et al.
Published: (2020-08-01)